Arteris (AIP) Is Down 6.0% After Raising 2026 Revenue Outlook And Naming New CFO
Arteris (AIP) reported mixed Q2 2026 results, with revenue rising to US$24.13 million but net loss widening to US$14.07 million. Despite raising its 2026 revenue outlook to US$95.0 million–US$98.0 million and appointing Saurabh Sinha as its new CFO, the company's stock fell 6.0%. The article highlights the ongoing tension between accelerating revenue growth, driven by AI and chiplet design activity, and increasing operating losses.
Nicholas Hawkins Sells 10,431 Shares of Arteris (NASDAQ:AIP) Stock
Arteris CFO Nicholas Hawkins sold 10,431 shares of Arteris (NASDAQ:AIP) stock for approximately $294,780, reducing his ownership by 9.83%. Despite this insider sale and a recent earnings miss, the stock rose 2.6%, and analysts maintain a "Moderate Buy" rating with an average price target of $41.00. Institutional investors hold a significant 64.36% of the company's stock.
Arteris CFO Nicholas B. Hawkins Executes Stock Option and Sells Shares in August 2026
Arteris, Inc.'s CFO, Nicholas B. Hawkins, executed multiple stock transactions in August 2026, including exercising a non-qualified stock option for 3,125 shares and selling a total of 10,631 shares. These transactions resulted in his direct beneficial ownership decreasing to 95,666 shares, while he still retains 31,250 non-qualified stock options with a $9.28 exercise price. The detailed activities were disclosed in a Form 4 filing.
Arteris | 4: Statement of changes in beneficial ownership of securities-Officer Hawkins Nicholas B.
This document is a statement of changes in beneficial ownership of securities for Officer Nicholas B. Hawkins of Arteris, filed under Form 4. It details transactions involving the company's securities by an insider.
AIP (AIP) insider Nicholas Hawkins outlines planned sale of 10,431 shares
Nicholas Hawkins, an insider at Arteris, Inc. (AIP), has filed to sell 10,431 shares of common stock, valued at approximately $294,828.04, through Morgan Stanley Smith Barney LLC. This proposed sale includes shares from restricted stock vesting on July 6, 2026, and an option exercise on August 13, 2026. The filing also reports significant past sales by Hawkins, including over 221,000 shares in May 2026.
Arteris | 144: Notice of proposed sale of securities pursuant to Rule 144
This article is a notice of a proposed sale of securities by Arteris, filed pursuant to Rule 144. It indicates that the company is intending to sell securities as per regulatory requirements.
Insider (AIP) files Form 144 notice for 200-share stock sale
Nicholas B. Hawkins, an insider at Arteris, Inc. (AIP), has filed a Form 144 notice to sell 200 shares of common stock through Morgan Stanley Smith Barney LLC on August 12, 2026, with an aggregate market value of $5,800. These shares stem from restricted stock vesting under a registered plan, acquired as compensation. Hawkins has also reported previous sales totaling over 224,000 shares in the past three months.
Arteris, Inc. 2026: Revenue $24.13M, EPS ($0.3) — 10-Q Summary
Arteris, Inc. (AIP) reported its 2026 quarterly results, showing a significant increase in revenue to $24.13 million, up 46.2% from the prior year. Despite revenue growth, the company recorded a net loss of ($14.07 million) and a diluted loss per share of ($0.30). The company attributed revenue growth to higher product demand, improved pricing, and a shift towards direct-to-consumer sales, with management expecting continued top-line expansion and margin improvement.
Arteris (NASDAQ:AIP) Shares Down 7.2% - Time to Sell?
Arteris (NASDAQ:AIP) shares dropped 7.2% to $27.63 on Monday, trading below its 50-day moving average, though above its 200-day average. The company recently missed quarterly EPS expectations, reporting a $0.10 loss per share against a projected $0.04 loss, despite slightly exceeding revenue forecasts. Despite a "Moderate Buy" consensus rating from analysts, significant insider selling, totaling nearly $52.2 million in shares over the past 90 days, raises questions about the stock's immediate future.
Arteris, Inc. (NASDAQ:AIP) Given Consensus Rating of "Moderate Buy" by Brokerages
Arteris, Inc. (NASDAQ:AIP) has received a "Moderate Buy" consensus rating from brokerages, with an average 12-month price target of $41.00. While the company exceeded revenue expectations in the second quarter and provided strong third-quarter and full-year guidance, it also reported a larger-than-expected loss per share. Insider selling has been noted, but institutional ownership remains strong, with a significant new position from BlackRock.
Jefferies upgrades Arteris stock rating on profitability outlook
Jefferies has upgraded Arteris, Inc. (NASDAQ:AIP) stock from Hold to Buy and raised its price target to $50.00, citing increased confidence in the company's path to non-GAAP profitability by Q4 2026. The firm notes that Arteris's growth story is expanding beyond AI to include security through the Cycuity acquisition, and it expects royalties to accelerate into 2028. This upgrade follows a strong performance with record bookings and a 46% revenue increase year-over-year, despite a wider-than-anticipated Q2 2026 loss per share.
Did Arteris' (AIP) Raised 2026 Outlook and AI Wins Just Recast Its Investment Narrative?
Arteris, Inc. reported Q2 2026 results with increased revenue and wider net losses, while also raising its full-year 2026 revenue outlook to US$95.0–US$98.0 million. The company highlighted record contract values, significant AI and data center design wins, and a new capital raise, reinforcing the relevance of its network-on-chip technology in complex semiconductor designs. Despite these positive developments and an upgraded outlook, the company continues to face challenges with profitability and potential dilution risks.
Did Arteris' (AIP) Raised 2026 Outlook and AI Wins Just Recast Its Investment Narrative?
Arteris, Inc. (AIP) recently reported its second-quarter 2026 results, showing increased revenue and a wider net loss, but also raised its full-year 2026 revenue outlook. The company highlighted record contract values, significant AI and data center design wins, and new capital raised, which strengthens its near-term revenue prospects. However, investors are cautioned about the ongoing losses, potential share dilution, and execution risks despite the growth path.
Arteris, Inc. Stock 12‑Month Price Target Raised to $41, Implies 30% Upside
The average 12-month price target for Arteris, Inc. (AIP) stock has been raised from $39.33 to $41 by 6 analysts, with forecasts ranging from $38 to $50 per share. This new target suggests a potential upside of approximately 30% from the Aug. 6 closing price. All 6 covering analysts maintain a "Buy" rating for the stock.
Sei Investments Co. Raises Position in Arteris, Inc. $AIP
Sei Investments Co. increased its stake in Arteris, Inc. (NASDAQ:AIP) by 43.1% in the first quarter, acquiring an additional 51,279 shares to own a total of 170,272 shares valued at $2.8 million. Despite institutional investor confidence and a "Moderate Buy" consensus rating from analysts with an average target price of $41, insider selling remains a concern, with nearly 1.5 million shares sold by company insiders totaling $52.2 million over the past 90 days. The company's Q2 earnings showed a revenue beat but a wider-than-expected adjusted loss per share, though Q3 and full-year 2026 revenue guidance exceeded consensus estimates.
Arteris (AIP) Stock Revenue Growth Collides With Widening Losses
Arteris (AIP) reported strong Q2 2026 revenue of US$24.1 million, driven by record annual contract value and royalties, indicating solid demand for its chip networking IP, particularly from AI and data center sectors. However, investor sentiment was negative due to widening losses, with net loss increasing to US$14.07 million and basic EPS loss deepening to US$0.30 per share, raising concerns about the company's path to profitability despite its growth.
Jefferies upgrades Arteris stock rating on profitability outlook
Jefferies has upgraded Arteris Inc. (NASDAQ:AIP) stock rating from Hold to Buy and increased its price target to $50.00, citing increased comfort with the company's path to non-GAAP profitability. The firm expects Arteris to achieve profitability by Q4 2026, driven by an 88% gross profit margin, expanding AI-related licensing growth, and contributions from the Cycuity acquisition. Despite a recent Q2 2026 loss, Arteris reported strong revenue, record bookings, and raised its full-year guidance, with Jefferies projecting significant earnings potential by 2030.
Arteris Inc (AIP) (Q2 2026) Earnings Call Highlights: Record ACV and Revenue Surge 46%
Arteris Inc. (AIP) reported a strong Q2 2026, with revenue surging 46% year-over-year to $24.1 million and annual contract value (ACV) plus royalties reaching a record $99.5 million. Despite a non-GAAP operating loss of $4.6 million, impacted by payroll taxes and commissions, the company raised its full-year 2026 revenue guidance to $95-$98 million and expects to achieve non-GAAP operating profitability by Q4 2026. Key growth drivers included major design wins with a hyperscale cloud company and a top US semiconductor firm, as well as the successful completion of an ATM program raising $72 million.
Arteris | 10-Q: Quarterly report
This article is a quarterly report (Form 10-Q) filed by Arteris. It provides a formal regulatory update on the company's financial performance and operations for the specified quarter.
Arteris, Inc. (AIP) Stock Price, News, Quote & History
This article provides comprehensive financial data for Arteris, Inc. (AIP), including its stock price, historical performance, key statistics, and analyst ratings. It also offers an overview of the company's semiconductor IP solutions and its market presence. The stock closed at $31.62, up 2.23%, but was down 6.10% in pre-market trading.
Arteris, Inc. (AIP) Reports Q2 Loss, Tops Revenue Estimates
Arteris, Inc. (AIP) reported a Q2 loss of $0.1 per share, which missed the Zacks Consensus Estimate of a $0.05 loss. However, the company's revenues for the quarter reached $24.13 million, surpassing the consensus estimate by 2.86%. Despite the earnings miss, Arteris shares have performed strongly year-to-date, gaining 99.6% compared to the S&P 500's 12.8% increase.
Arteris Q2 Earnings Call Highlights
Arteris reported record second-quarter results for 2026, with significant growth in revenue, annual contract value plus royalties, and remaining performance obligations, driven by strong demand across multiple sectors including enterprise computing and automotive. The company highlighted key wins in AI infrastructure and an expanded partnership with Arm for cybersecurity assurance, while also raising its full-year revenue outlook. Saurabh Sinha will become the new CFO on September 8th.
Arteris Q2 2026 slides: record revenue, royalties mask profitability gap
Arteris Inc. reported record revenue of $24.1 million and annual contract value plus royalties of $99.5 million for Q2 2026, both exceeding guidance. Despite strong top-line growth driven by demand in AI, data center, and automotive markets, the company posted a wider-than-expected non-GAAP operating loss of $4.6 million, causing its shares to fall. Arteris raised its full-year 2026 revenue outlook but also widened its operating loss forecast, highlighting the ongoing challenge of achieving profitability amidst significant expansion.
Arteris Announces Financial Results for the Second Quarter and Estimated Third Quarter and Updated Full Year 2026 Guidance
Arteris (Nasdaq: AIP) announced record-breaking financial results for Q2 2026, including 46% year-over-year revenue growth to $24.1 million and 44% growth in Annual Contract Value plus royalties to $99.5 million. The company reported strong customer engagement in various markets, with a 21% increase in design starts, largely driven by AI compute integration. Arteris also provided Q3 and updated full-year 2026 guidance, expecting continued growth and announced Saurabh Sinha will join as CFO.
Arteris earnings up next: Can chip IP play sustain AI momentum?
Arteris Inc. is set to report second-quarter results, with analysts expecting a loss of 4 cents per share on revenue of $23.5 million, reflecting significant year-over-year growth. Investors will focus on the acceleration of royalty revenue from automotive and AI design wins, and the company's path to sustained profitability, despite high gross margins. Management's commentary on design win momentum, especially from AI-enabled systems and the UCIe chiplet interconnect standard, will also be crucial.
Arteris Appoints Saurabh Sinha as Chief Financial Officer
Arteris, Inc. (Nasdaq: AIP) has announced the appointment of Saurabh Sinha as its new Chief Financial Officer, effective September 8, 2026. Sinha succeeds Nick Hawkins, who is retiring after seven years with the company and will assist with the transition. The company's President and CEO, K. Charles Janac, highlighted Sinha's extensive financial leadership experience in technology companies and expressed confidence in his ability to help Arteris scale and execute its long-term strategy in the AI and semiconductor innovation market.
Arteris CFO Nick Hawkins Retires After Seven Years With Company
Arteris (Nasdaq: AIP) announced the appointment of Saurabh Sinha as Chief Financial Officer, effective September 8, 2026. He will succeed Nick Hawkins, who is retiring after seven years but will remain as an advisor for a smooth transition. Sinha brings over 25 years of financial leadership experience from technology companies, including his recent role as CFO of Aeva Technologies.
Bayview Legacy sells 100,000 Arteris, Inc. (AIP) shares via plan
Bayview Legacy, LLC, a 10% owner of Arteris, Inc. (AIP), reported selling 100,000 shares of common stock through five indirect open-market transactions on August 3-4, 2026. These sales were executed under a Rule 10b5-1 trading plan adopted on December 12, 2025, with shares sold at weighted-average prices ranging from $28.17 to $32.48. K. Charles Janac, Bayview's manager, is deemed to have voting and dispositive power over these shares and also reported the transactions separately.
Arteris | 4: Statement of changes in beneficial ownership of securities-10% Owner Bayview Legacy, LLC
This document, titled "Arteris | 4: Statement of changes in beneficial ownership of securities-10% Owner Bayview Legacy, LLC," is a Form 4 filing. It indicates a statement of changes in beneficial ownership of securities for Arteris, specifically concerning Bayview Legacy, LLC, which is a 10% owner. The filing is a standard regulatory disclosure detailing changes in security holdings.
Arteris, Inc. (NASDAQ: AIP) director trades 70,000 shares in 10b5-1 plan
Saiyed Atiq Raza, a director at Arteris, Inc. (NASDAQ: AIP), sold a total of 70,000 common shares on August 3, 2026, through a revocable trust. The sales were executed in three separate open-market transactions at weighted average prices ranging from $28.7765 to $30.3009 per share, as part of a pre-arranged Rule 10b5-1 trading plan adopted in November 2025. Following these transactions, Raza directly holds 4,703 common shares of Arteris.
Arteris (AIP) counsel exercises 4,000 options, sells stock under 10b5-1 plan
Arteris, Inc.'s VP and General Counsel, Paul L. Alpern, exercised 4,000 incentive stock options at $0.56 per share on August 3, 2026, and subsequently sold 4,000 shares at weighted-average prices of $29.11 and $30.1991 under a pre-arranged 10b5-1 trading plan. After these transactions, Alpern retains 53,000 outstanding options from the same grant and 70,733 shares of common stock. The transactions were conducted according to a plan adopted in February 2026, aiming for transparency in insider trading.
This Rubrik Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Loop Capital initiated coverage on Rubrik Inc (RBRK) with a Buy rating and a $100 price target. This article highlights five top analyst initiations for Tuesday, including coverage on Arteris Inc (AIP) by Roth Capital with a Buy rating and a $40 price target, and SK Hynix Inc – ADR (SKHY) by Stifel with a Buy rating and a $240 price target. DA Davidson initiated Sailpoint Inc (SAIL) with a Neutral rating and a $17 price target, while Wells Fargo initiated PDF Solutions Inc (PDFS) with an Equal-Weight rating and a $50 price target.
Arteris | 144: Notice of proposed sale of securities pursuant to Rule 144
This document is a formal notice of the proposed sale of securities by Arteris, filed in accordance with Rule 144. It indicates an intention to sell shares under specific conditions governed by this SEC rule.
Arteris | 144: Notice of proposed sale of securities pursuant to Rule 144
The document is a Form 144 filing by Arteris, indicating a proposed sale of securities. This filing is required under Rule 144 of the Securities Act of 1933, pertaining to the resale of restricted and controlled securities.
Form 144 ARTERIS INC For: 3 August By Investing.com
This article from Investing.com is a simple, brief announcement titled "Form 144 ARTERIS INC For: 3 August." It serves primarily as a notification about a Form 144 filing for Arteris Inc. on August 3rd, indicating insider transactions or sales of restricted securities. The article provides no further details beyond this announcement.
Form 144 ARTERIS INC For: 3 August By Investing.com
This article from Investing.com announces the filing of Form 144 for ARTERIS INC on August 3rd. Form 144 is a notice of the intent to sell restricted securities without registration. The brief notice provides no additional details beyond the company name and filing date.
AIP (NASDAQ: AIP) insider schedules 18,500-share option-related sale
Paul Lawrence Alpern, an insider at Arteris, Inc. (NASDAQ: AIP), has filed to sell 18,500 shares of common stock on August 3, 2026, which will be issued upon the cash exercise of stock options. The filing also detailed several past sales made under a Rule 10b5-1 trading plan in June and July 2026, totaling over 28,000 shares. The aggregate market value of the planned sale is $552,780.00.
Arteris (AIP) trust plans 70,000-share NASDAQ sale after prior 10b5-1 trades
An insider trust related to Arteris (AIP), the Atiq Raza & N. Saraiya 2012 Revocable Trust, plans to sell 70,000 shares of common stock on NASDAQ, with an aggregate market value of $2,091,600, on or after August 3, 2026. These shares were acquired via stock options in 2020. This planned sale follows several prior 10b5-1 sales by the trust within the last three months, totaling over 160,000 shares for a value exceeding $6.4 million.
Earnings Preview: Arteris to Report Financial Results Post-market on August 06
Arteris (NASDAQ: AIP) is scheduled to announce its financial results after the market closes on August 6. Analysts are forecasting earnings of $-0.13 per share and revenue of $14.18 million. Investors will be closely watching for any updates on the company's financial guidance for the upcoming quarter and the full fiscal year.
AIP|Arteris Inc|Price:30.120|Chg%:+0.820
This article provides a comprehensive stock analysis of Arteris Inc (AIP), highlighting its stable fundamentals, high growth potential, and fair valuation. The company is experiencing revenue growth and increased institutional ownership, with analysts rating it as a "Buy." The report also details Arteris's core business in semiconductor system IP and outlines various scores for financial health, valuation, earnings forecast, price momentum, institutional confidence, and risk assessment.
Arteris Inc (AIP) Institutional Confidence
The article discusses the institutional confidence score for Arteris Inc (AIP), which is currently 5.00, ranking 220 out of 486 in the Software & IT Services industry. Institutional shareholding proportion stands at 56.91%, showing a 13.42% quarter-over-quarter increase. Bill Nygren | OAKMX is noted as the largest institutional shareholder despite a significant decrease in holdings, and the article also lists other major institutional shareholders and their recent activity.
Will Arteris, Inc. (AIP) Report Negative Earnings Next Week? What You Should Know
Arteris, Inc. (AIP) is expected to have a year-over-year increase in earnings on higher revenues for the quarter ended June 2026, though analysts have recently revised their EPS estimates lower. The company carries a Zacks Rank of #3 and an Earnings ESP of -20.00%, making a conclusive prediction of an earnings beat difficult. However, its competitor Block (XYZ) is predicted to beat EPS estimates with an Earnings ESP of +0.23% and a Zacks Rank #2.
Arteris Inc (AIP) Technical Analysis: Support, Resistance, Indicators & Moving Averages
This article provides a technical analysis of Arteris Inc (AIP), detailing its support and resistance levels, price momentum score, and various technical indicators. It notes that the stock is currently trading between a resistance level of 41.02 and a support level of 19.77, making it suitable for range-bound swing trading. The analysis also includes summaries from commonly used technical indicators and moving averages, offering insights into potential buy/sell signals.
Arteris Inc (AIP) Financial Health: Profitability & Balance Sheet Analysis
This article analyzes the financial health of Arteris Inc (AIP), assigning it a score of 6.55 out of 486 in the Software & IT Services industry, indicating weak financial status and low operational efficiency. Despite this, the company reported a significant year-over-year revenue increase of 38.74% to $22.94 million and a net profit increase of 1.99%. The analysis also touches on several financial dimensions including quality of earnings, operational efficiency, growth potential, and shareholder returns, noting that relevant data for these categories has not yet been disclosed by the company.
AIP|Arteris Inc|Price:30.260|
This article provides a detailed company profile for Arteris Inc. (AIP), a provider of semiconductor system IP. It includes financial data, market performance, an overview of its product platforms like Network-on-Chip IP and SoC Integration Automation Software, and a list of company executives with their shareholdings. The report also highlights that licensing, support, and maintenance are the biggest revenue sources for Arteris Inc.
BlackRock, Inc. (AIP) discloses 6.2% beneficial stake in Arteris shares
BlackRock, Inc. has filed a Schedule 13G disclosing a 6.2% passive beneficial ownership stake in Arteris, Inc. common stock as of June 30, 2026. The filing indicates BlackRock owns 2,884,824 shares, with sole voting power over 2,828,242 shares and sole dispositive power over all 2,884,824 shares. No single underlying client holds more than five percent of Arteris’s outstanding common shares.
Arteris Inc (AIP) Income Statement
This article presents the quarterly and annual income statements for Arteris Inc (AIP), providing detailed financial data from FY2020Q3 through FY2026Q1. It includes key metrics such as total revenue, cost of revenue, operating expenses, net income, and earnings per share. The document also features an FAQ section explaining how to interpret income statements and defining important financial terms related to AIP's performance.
Arteris Inc (AIP) Cash Flow
This article provides a detailed cash flow statement for Arteris Inc (AIP), covering annual and quarterly data for operating, investing, and financing activities. It includes year-over-year percentage changes and absolute financial figures for various cash flow components. The page also features FAQs explaining key cash flow concepts and Arteris Inc's specific cash flow performance.
ETFs Investing in Arteris, Inc. Stocks
This article lists various ETFs that include Arteris, Inc. (AIP) stocks in their holdings. The ETFs are sorted by market value and provide details such as issuer, management style, focus, expense ratio, and AUM. The information aims to help investors find accessible and diversified opportunities with lower risk.
Arteris, Inc. Revenue Breakdown – NASDAQ:AIP
Arteris, Inc. (NASDAQ: AIP) generated 70.58 million USD in revenue last year. The primary contributor was its Licensing, Support and Maintenance segment, which brought in 63.86 million USD. Geographically, the United States was the top revenue source, accounting for 28.01 million USD.
